Paid Rheumatoid Arthritis (RA) Clinical Trial Now Enrolling at Achieve ... PR Web (press release) Achieve is conducting a study to evaluate the safety and efficacy of a new drug versus rituximab in patients with moderately to severely active rheumatoid arthritis (RA). Share on Twitter Share on Facebook Share on Google+ Share on LinkedIn Email a friend. |
